FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 106 filers reported holding FULCRUM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,357 | -53.5% | 1,657 | -65.4% | 0.00% | – |
| Q2 2023 | $15,810 | +7253.5% | 4,791 | -93.7% | 0.00% | – |
| Q1 2023 | $215 | -50.6% | 75,507 | +26.4% | 0.00% | -100.0% |
| Q4 2022 | $435 | -99.9% | 59,730 | +17.7% | 0.00% | 0.0% |
| Q3 2022 | $410,000 | +76.0% | 50,727 | +6.7% | 0.00% | – |
| Q2 2022 | $233,000 | -71.1% | 47,527 | +39.3% | 0.00% | -100.0% |
| Q1 2022 | $807,000 | +43.9% | 34,115 | +7.6% | 0.00% | 0.0% |
| Q4 2021 | $561,000 | -34.2% | 31,707 | +5.0% | 0.00% | 0.0% |
| Q3 2021 | $852,000 | +261.0% | 30,199 | +34.4% | 0.00% | – |
| Q2 2021 | $236,000 | +61.6% | 22,475 | +81.9% | 0.00% | – |
| Q1 2021 | $146,000 | +5.0% | 12,355 | +4.1% | 0.00% | – |
| Q4 2020 | $139,000 | +65.5% | 11,865 | +11.8% | 0.00% | – |
| Q3 2020 | $84,000 | -63.9% | 10,615 | -16.6% | 0.00% | – |
| Q2 2020 | $233,000 | – | 12,725 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,962,202 | $19,415,000 | 7.94% |
| TRV GP IV, LLC | 2,343,154 | $11,481,000 | 7.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 949 | $193,741,000 | 2.02% |
| Logos Global Management LP | 1,950,000 | $9,555,000 | 1.75% |
| COWEN AND COMPANY, LLC | 2,385,885 | $11,691,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,355,624 | $16,443,000 | 0.62% |
| ACUTA CAPITAL PARTNERS, LLC | 200,000 | $980,000 | 0.55% |
| RTW INVESTMENTS, LP | 3,961,194 | $19,410,000 | 0.50% |
| Parkman Healthcare Partners LLC | 262,689 | $1,287,000 | 0.47% |
| Deep Track Capital, LP | 1,000,000 | $4,900,000 | 0.32% |